Esperion Therapeutics
ESPR
ESPR
136 hedge funds and large institutions have $352M invested in Esperion Therapeutics in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
5.14% more ownership
Funds ownership: 82.66% → 87.8% (+5.1%)
3% more funds holding
Funds holding: 132 → 136 (+4)
0% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 42
Holders
136
Holding in Top 10
3
Calls
$14.4M
Puts
$2.78M
Top Buyers
| 1 | +$13.1M | |
| 2 | +$9.27M | |
| 3 | +$6.76M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.37M |
| 5 |
BlackRock
New York
|
+$3.37M |
Top Sellers
| 1 | -$8.48M | |
| 2 | -$6.93M | |
| 3 | -$3.82M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$2.54M |
| 5 |
MAM
Monaco Asset Management
Monaco
|
-$1.57M |